SMURF2 and neoplasm: The relationship between SMURF2 expression and tumor grade in LUAD was evaluated by UALCAN database (http://ualcan.path.uab.edu/index.html), and the results suggested that patients with LUAD at stage three exhibited low SMURF2 expression (Figure 1E, P < 0.05).